HEALTHY EXTRACTS INC. (HYEX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 800K 1.6M 2.4M Q1 '15: 10.6K Q2 '15: 34.8K Q3 '15: 25K Q4 '15: 45.1K Q1 '16: 39K Q2 '16: 41.2K Q3 '16: 42.5K Q4 '16: 40K Q1 '17: 42K Q2 '17: 37.5K Q3 '17: 34.5K Q4 '17: 14.1K Q1 '18: 19.9K Q2 '18: 31.1K Q3 '18: 15.2K Q4 '18: 1K Q1 '19: 97.3K Q2 '19: 201K Q3 '19: 273.3K Q4 '19: 176.8K Q1 '20: 151.7K Q2 '20: 151.7K Q3 '20: 536.6K Q4 '20: 135.9K Q1 '21: 181K Q2 '21: 278.5K Q3 '21: 448K Q4 '21: 773.5K Q1 '22: 551.7K Q2 '22: 469.8K Q3 '22: 499.7K Q4 '22: 818.6K Q1 '23: 614.9K Q2 '23: 588.5K Q3 '23: 613.5K Q4 '23: 668.9K Q1 '24: 688.8K Q2 '24: 908.4K Q3 '24: 744.9K Q4 '24: 771.2K Q1 '25: 931.3K Q2 '25: 968.7K Q3 '25: 918K Q4 '25: 1.7M Q1 '26: 1.6M Q2 '26: 2.1M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Gross Profit Quarterly

-500K 0 500K 1M 1.5M Q3 '15: -13.1K Q1 '17: 39K Q2 '17: 22.8K Q3 '17: 22.5K Q1 '18: 5.2K Q2 '18: 20.2K Q3 '18: 16K Q1 '19: 65.5K Q2 '19: 154.8K Q3 '19: 257.4K Q1 '20: 131.1K Q2 '20: 131.1K Q3 '20: 306.6K Q1 '21: 129K Q2 '21: 210.1K Q3 '21: 307.6K Q4 '21: 48.3K Q1 '22: 324.7K Q2 '22: 274.3K Q3 '22: 431.1K Q4 '22: 341.5K Q1 '23: 277.8K Q2 '23: 285.1K Q3 '23: 493.2K Q4 '23: 565.7K Q1 '24: 408.4K Q2 '24: 486.1K Q3 '24: 602.5K Q4 '24: 414.4K Q1 '25: 425K Q2 '25: 592.8K Q3 '25: 447.2K Q4 '25: 957.4K Q1 '26: 988.7K Q2 '26: 1.5M Q1 '18 Q3 '19 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Income Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Net Income Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q1 '15: -22.2K Q2 '15: -107.4K Q3 '15: -218.5K Q4 '15: -382.8K Q1 '16: -331.6K Q2 '16: -108.8K Q3 '16: -875.6K Q4 '16: -2.1M Q1 '17: -498.2K Q2 '17: -131.5K Q3 '17: -1.5M Q4 '17: -1.4M Q1 '18: -64.4K Q2 '18: -399.7K Q3 '18: -757K Q4 '18: -2.1M Q1 '19: 1.6M Q2 '19: -278.4K Q3 '19: -643.6K Q4 '19: -37.9K Q1 '20: -3.4M Q2 '20: -3.4M Q3 '20: 1.8M Q4 '20: -1.6M Q1 '21: -1.3M Q2 '21: -557.8K Q3 '21: -672.5K Q4 '21: 536.7K Q1 '22: 3K Q2 '22: -859.3K Q3 '22: -170.2K Q4 '22: 43.4K Q1 '23: -579.2K Q2 '23: -1.3M Q3 '23: -247.9K Q4 '23: -378.6K Q1 '24: -861.3K Q2 '24: 113.5K Q3 '24: 354.5K Q4 '24: -446.9K Q1 '25: -398.9K Q2 '25: 67.1K Q3 '25: -395.4K Q4 '25: -154K Q1 '26: -200.6K Q2 '26: -129.4K Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Cost of Revenue Quarterly

-500K 0 500K 1M 1.5M Q2 '15: 1.3K Q3 '15: 38.1K Q4 '15: 7.3K Q1 '16: 11.6K Q2 '16: 0 Q3 '16: 5.2K Q4 '16: 10.1K Q1 '17: 3K Q2 '17: 14.7K Q3 '17: 12K Q1 '18: 14.7K Q2 '18: 10.9K Q3 '18: -839 Q4 '18: 3.8K Q1 '19: 31.8K Q2 '19: 46.2K Q3 '19: 15.9K Q4 '19: 430.6K Q1 '20: 20.6K Q2 '20: 20.6K Q3 '20: 226.5K Q4 '20: 1.4M Q1 '21: 41.4K Q2 '21: 33.8K Q3 '21: 72.2K Q4 '21: 409.5K Q1 '22: 226.9K Q2 '22: 195.6K Q3 '22: 68.6K Q4 '22: 477.2K Q1 '23: 337.1K Q2 '23: 303.4K Q3 '23: 120.3K Q4 '23: 103.2K Q1 '24: 280.4K Q2 '24: 422.3K Q3 '24: 142.5K Q4 '24: 356.8K Q1 '25: 506.3K Q2 '25: 375.8K Q3 '25: 470.7K Q4 '25: 736.7K Q1 '26: 622K Q2 '26: 614.8K Q3 '15 Q1 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Operating Cash Flow Quarterly

-2.4M -1.6M -800K 0 800K 1.6M 2.4M Q1 '15: -32.8K Q2 '15: -90.5K Q3 '15: -188.2K Q4 '15: -186.4K Q1 '16: -102.6K Q2 '16: -72.9K Q3 '16: -168K Q4 '16: -193.6K Q1 '17: -225.2K Q2 '17: -130.1K Q3 '17: -62.6K Q4 '17: -254.3K Q1 '18: -188.2K Q2 '18: -114K Q3 '18: -22K Q4 '18: -4.5K Q1 '19: -2.2M Q2 '19: 0 Q3 '19: -789K Q4 '19: 1.2M Q1 '20: -175.4K Q2 '20: -1.7M Q3 '20: -1M Q4 '20: 986.1K Q1 '21: -635.3K Q2 '21: -33.6K Q3 '21: -273.3K Q4 '21: 40.9K Q1 '22: -108.4K Q2 '22: -48.9K Q3 '22: -86.3K Q4 '22: -147K Q1 '23: -342.9K Q2 '23: -60.6K Q3 '23: -67.9K Q4 '23: 55.6K Q1 '24: 18.7K Q2 '24: 169.1K Q3 '24: 52.3K Q4 '24: 41.9K Q1 '25: 60K Q2 '25: 17.2K Q3 '25: -279.9K Q1 '26: 106K Q2 '26: 306K Q3 '15 Q1 '17 Q3 '18 Q1 '20 Q3 '21 Q1 '23 Q3 '24 Q2 '26

Free Cash Flow Quarterly

-2.4M -1.6M -800K 0 800K 1.6M 2.4M Q1 '19: -2.2M Q2 '19: 0 Q3 '19: -789K Q4 '19: 1.2M Q1 '21: -635.3K Q2 '21: -33.6K Q3 '21: -273.3K Q4 '21: 40.9K Q1 '22: -116.4K Q2 '22: -48.9K Q3 '22: -86.3K Q4 '22: -147K Q1 '23: -342.9K Q2 '23: -60.6K Q3 '23: -67.9K Q4 '23: 55.6K Q1 '24: 18.7K Q2 '24: 169.1K Q3 '19 Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

EPS TTM

-18.00 -12.00 -6.00 0.00 6.00 12.00 18.00 Q4 '15: -0.06 Q1 '16: -0.08 Q2 '16: -0.08 Q3 '16: -0.12 Q4 '16: -0.21 Q1 '17: -0.22 Q2 '17: -1.59 Q3 '17: -13.16 Q4 '17: -15.82 Q1 '18: -15.79 Q2 '18: -14.62 Q3 '18: -3.39 Q4 '18: -1.09 Q1 '19: -1.07 Q2 '19: -0.86 Q3 '19: -0.47 Q4 '19: 0.01 Q1 '20: -0.03 Q2 '20: -0.05 Q3 '20: -0.03 Q4 '20: -0.01 Q1 '21: 0.01 Q2 '21: 0.03 Q3 '21: 0.02 Q2 '16 Q1 '17 Q4 '17 Q3 '18 Q2 '19 Q1 '20 Q4 '20 Q3 '21

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.